- How to pick specific iPSC colonies consistently and reliably for further testing or culture while maintaining high levels of cell health
- How to monitor delicate iPSC line culture morphology and growth characteristics without removing plates from the incubator
- The skills needed to use minimal sample volumes required to characterize precious cell types, with minimal attrition for downstream requirements

- The journey of Heartseed’s investigative cardiomyocyte therapy for heart failure patients, now in Phase I/II clinical trials
- The value albumin delivers across advanced therapy applications
- How implementing Recombumin® into a manufacturing process can help improve production and support stability
- The key benefits of using chemically defined raw materials

In this GEN webinar, Dr. Aleš Štrancar will discuss various chromatographic methods to consistently separate empty, partial, and full capsids in large-scale AAV manufacturing. He will introduce the CIMmultus High Reproducibility columns by Sartorius BIA Separations, which have better resolution and use narrow acceptance criteria to ensure consistent results.

- Join us for a captivating webinar on how to reduce Per- and Polyfluoroalkyl Substances (PFAS) contamination in water samples below the detection limit.
- In this session, we will explore the world of PFAS - where they originate, their adverse and health impacts, and the steps taken by regulatory bodies.
- Discover how the Sartorius Arium® Water System revolutionizes the fight against PFAS contamination in water for analytical purposes, eradicating false positives and background noise that can compromise your chromatographic and spectroscopic results. We will provide an in-depth look into our experimental design, showcasing sampling points, method selection, and method of detection limits.

- Expert will discuss the latest advancements in mRNA-based CAR-T cell therapy for cancer treatment.
- Expert will share her experiences and insights on the potential of this technology to revolutionize cancer treatment.
- We will also discuss the latest research and clinical trials and explore the potential of mRNA-based CAR-T cell therapy to revolutionize cancer treatment.
- Dr. Sandy will share her deep knowledge on how mRNA should be designed for T cell therapy and delivered to T cells.Experts will discuss the latest advancements in mRNA-based CAR-T cell therapy for cancer treatment. They will share their experiences and insights on the potential of this technology to revolutionize cancer treatment. We will discuss the latest research and clinical trials and explore the potential of mRNA-based CAR-T cell therapy to revolutionize cancer treatment. Expert will explain how mRNA should be designed for T cell therapy and delivered to T cells.

- Keep up with cutting-edge developments from expert speakers
- Access the latest written guides, posters, technical papers and more in our resource hubs
- Discover new technology launches and innovations
- Ask the experts - live Q&As with guest speakers and manufacturers